Cargando…
Micrococcus spp. as a promising source for drug discovery: A review
Historically, bacteria of the phylum, Actinobacteria have been a very prominent source of bioactive compounds for drug discovery. Among the actinobacterial genera, Micrococcus has not generally been prioritized in the search for novel drugs. The bacteria in this genus are known to have very small ge...
Autores principales: | Tizabi, Daniela, Hill, Russell T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548855/ https://www.ncbi.nlm.nih.gov/pubmed/37460166 http://dx.doi.org/10.1093/jimb/kuad017 |
Ejemplares similares
-
Genome mining for drug discovery: progress at the front end
por: Baltz, Richard H
Publicado: (2021) -
Genome mining for drug discovery: cyclic lipopeptides related to daptomycin
por: Baltz, Richard H
Publicado: (2021) -
Discovery of an alternative pathway of peptidoglycan biosynthesis: A new target for pathway specific inhibitors
por: Ogasawara, Yasushi, et al.
Publicado: (2021) -
Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture
por: Kim, Ji Hun, et al.
Publicado: (2021) -
Discovery of ammosesters by mining the Streptomyces uncialis DCA2648 genome revealing new insight into ammosamide biosynthesis
por: Luo, Jun, et al.
Publicado: (2021)